These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 28276682

  • 21. Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models.
    Göschl S, Schreiber-Brynzak E, Pichler V, Cseh K, Heffeter P, Jungwirth U, Jakupec MA, Berger W, Keppler BK.
    Metallomics; 2017 Mar 22; 9(3):309-322. PubMed ID: 28205649
    [Abstract] [Full Text] [Related]

  • 22. Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes.
    Jin S, Hao Y, Zhu Z, Muhammad N, Zhang Z, Wang K, Guo Y, Guo Z, Wang X.
    Inorg Chem; 2018 Sep 04; 57(17):11135-11145. PubMed ID: 30117731
    [Abstract] [Full Text] [Related]

  • 23. Conjugation of platinum(IV) complexes with chlorambucil to overcome cisplatin resistance via a "joint action" mode toward DNA.
    Qin X, Fang L, Chen F, Gou S.
    Eur J Med Chem; 2017 Sep 08; 137():167-175. PubMed ID: 28586717
    [Abstract] [Full Text] [Related]

  • 24. Platinum-Based Modification of Styrylbenzylsulfones as Multifunctional Antitumor Agents: Targeting the RAS/RAF Pathway, Enhancing Antitumor Activity, and Overcoming Multidrug Resistance.
    Liu Z, Wang M, Wang H, Fang L, Gou S.
    J Med Chem; 2020 Jan 09; 63(1):186-204. PubMed ID: 31820986
    [Abstract] [Full Text] [Related]

  • 25. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
    Yu H, Gou S, Wang Z, Chen F, Fang L.
    Eur J Med Chem; 2016 May 23; 114():141-52. PubMed ID: 26974381
    [Abstract] [Full Text] [Related]

  • 26. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR.
    Cancer Res; 1993 Jun 01; 53(11):2581-6. PubMed ID: 8388318
    [Abstract] [Full Text] [Related]

  • 27. Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance.
    Wang M, Li G, Jiang G, Cai J, Liu Z, Huang R, Huang X, Wang H.
    J Med Chem; 2024 Apr 25; 67(8):6218-6237. PubMed ID: 38573870
    [Abstract] [Full Text] [Related]

  • 28. Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.
    Xu Z, Wang Z, Yiu SM, Zhu G.
    Dalton Trans; 2015 Dec 14; 44(46):19918-26. PubMed ID: 26514681
    [Abstract] [Full Text] [Related]

  • 29. Platinum(II) complexes with mono-aminophosphonate ester targeting group that induce apoptosis through G1 cell-cycle arrest: synthesis, crystal structure and antitumour activity.
    Huang KB, Chen ZF, Liu YC, Li ZQ, Wei JH, Wang M, Zhang GH, Liang H.
    Eur J Med Chem; 2013 May 14; 63():76-84. PubMed ID: 23455059
    [Abstract] [Full Text] [Related]

  • 30. Novel phenylenediamine bridged mixed ligands dimetallic square planner Pt(II) complex inhibits MMPs expression via p53 and caspase-dependent signaling and suppress cancer metastasis and invasion.
    Rahman FU, Ali A, Khan IU, Duong HQ, Guo R, Wang H, Li ZT, Zhang DW.
    Eur J Med Chem; 2017 Jan 05; 125():1064-1075. PubMed ID: 27810593
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM, Sarju J, Wagner G.
    J Med Chem; 2008 Jan 10; 51(1):135-41. PubMed ID: 18072719
    [Abstract] [Full Text] [Related]

  • 32. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
    Ma R, Wang Y, Yan L, Ma L, Wang Z, Chan HC, Chiu SK, Chen X, Zhu G.
    Chem Commun (Camb); 2015 May 07; 51(37):7859-62. PubMed ID: 25854514
    [Abstract] [Full Text] [Related]

  • 33. The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy.
    Xiao H, Song H, Zhang Y, Qi R, Wang R, Xie Z, Huang Y, Li Y, Wu Y, Jing X.
    Biomaterials; 2012 Nov 07; 33(33):8657-69. PubMed ID: 22938766
    [Abstract] [Full Text] [Related]

  • 34. Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria.
    Chen H, Chen F, Hu W, Gou S.
    J Inorg Biochem; 2018 Mar 07; 180():119-128. PubMed ID: 29253663
    [Abstract] [Full Text] [Related]

  • 35. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S, Takayama H, Suzuki T, Odani A, Yamori T, Chikuma M.
    Metallomics; 2013 May 07; 5(5):461-8. PubMed ID: 23608770
    [Abstract] [Full Text] [Related]

  • 36. Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate.
    Qiao X, Gao YY, Zheng LX, Ding XJ, Xu LW, Hu JJ, Gao WZ, Xu JY.
    Eur J Med Chem; 2021 Nov 05; 223():113730. PubMed ID: 34388483
    [Abstract] [Full Text] [Related]

  • 37. Combretastatin A-4 Analogue: A Dual-Targeting and Tubulin Inhibitor Containing Antitumor Pt(IV) Moiety with a Unique Mode of Action.
    Huang X, Huang R, Gou S, Wang Z, Liao Z, Wang H.
    Bioconjug Chem; 2016 Sep 21; 27(9):2132-48. PubMed ID: 27494235
    [Abstract] [Full Text] [Related]

  • 38. Unsymmetric mono- and dinuclear platinum(IV) complexes featuring an ethylene glycol moiety: synthesis, characterization, and biological activity.
    Pichler V, Heffeter P, Valiahdi SM, Kowol CR, Egger A, Berger W, Jakupec MA, Galanski MS, Keppler BK.
    J Med Chem; 2012 Dec 27; 55(24):11052-61. PubMed ID: 23194425
    [Abstract] [Full Text] [Related]

  • 39. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
    Kelland LR, Barnard CF, Mellish KJ, Jones M, Goddard PM, Valenti M, Bryant A, Murrer BA, Harrap KR.
    Cancer Res; 1994 Nov 01; 54(21):5618-22. PubMed ID: 7923207
    [Abstract] [Full Text] [Related]

  • 40. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV, Yung T, Bogdanov AA, Shchebet A, Johnsen SA, Lyakhov AS, Ivashkevich LS, Ibrahimava ZA, Garbuzenco TS, Kolesnikova TS, Melnova NI, Gaponik PN, Ivashkevich OA.
    J Inorg Biochem; 2013 Mar 01; 120():44-53. PubMed ID: 23305964
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.